Histo-blood Group P: Biosynthesis of Globoseries Glycolipids in EBV-transformed B Cell Lines

Overview

Journal Glycoconj J

Publisher Springer

Specialties Biochemistry
Endocrinology

Date 1996 Aug 1

PMID 8872109

Authors

J Wiels

S Taga

C Tetaud

B Cedergren

B Nilsson

H Clausen

Affiliations

Soon will be listed here.

Abstract

The genetic and biosynthetic basis of the histo-blood group P-system is not fully understood. Individuals with the rare p phenotype do not express the three glycolipid antigens (Pk, P and P1) of this system, probably because of deficiencies in glycosyltransferases involved in their biosynthesis. Iiuka et al. [Iiuka S, Chen SH, Yoshida A (1986) Biochem Biophys Res Commun 137: 1187-95], however, previously reported that detergent extracts from an EBV-transformed B cell line derived from a p individual did express the glycosyltransferase activity (Pk transferase) assumed to be missing in this blood group status. Here, we have reinvestigated the antigen expression and glycosyltransferase activities in two p individuals by analysing EBV-transformed cell lines as well as erythrocytes to confirm the blood group P status. The thin layer chromatography glycolipid profile of extracts from erythrocytes and EBV-transformed B cell lines showed characteristic accumulation of lactosylceramide and absence of Pk and P antigens. Glycosyltransferase activities of the B cell lines were analysed using glycolipid substrates and both extracts were found to contain lactosylceramide synthetase and P transferase activities but to be completely devoid of Pk transferase activity. The presented data indicate that p individuals, in contrast to previous reports, do not express a functional Pk glycosyltransferase.

References

Fellous M, Cartron J, Wiels J, Tursz T . A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pk red blood cell specificity. Br J Haematol. 1985; 60(3):559-65. DOI: 10.1111/j.1365-2141.1985.tb07454.x. View

Kojima H, Tsuchiya S, Sekiguchi K, Gelinas R, Hakomori S . Predefined gene transfer for expression of a glycosphingolipid antigen by transfection with a cosmid genomic library prepared from a cell line in which the specific glycosphingolipid is highly expressed. Biochem Biophys Res Commun. 1987; 143(2):716-22. DOI: 10.1016/0006-291x(87)91413-6. View

Kijimoto-Ochiai S, Naiki M, Makita A . Defects of glycosyltransferase activities in human fibroblasts of Pk and p blood group phenotypes. Proc Natl Acad Sci U S A. 1977; 74(12):5407-10. PMC: 431739. DOI: 10.1073/pnas.74.12.5407. View

Symington F, Bernstein I, Hakomori S . Monoclonal antibody specific for lactosylceramide. J Biol Chem. 1984; 259(9):6008-12. View

Wiels J, Holmes E, COCHRAN N, Tursz T, Hakomori S . Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. J Biol Chem. 1984; 259(23):14783-7. View

Taniguchi N, Yanagisawa K, Makita A, Naiki M . Purification and properties of rat liver globotriaosylceramide synthase, UDP-galactose:lactosylceramide alpha 1-4-galactosyltransferase. J Biol Chem. 1985; 260(8):4908-13. View

von dem Borne A, Bos M, Tromp J, Vant Veer M, Tetteroo P . A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol. 1986; 63(1):35-46. DOI: 10.1111/j.1365-2141.1986.tb07492.x. View

Clausen H, Bennett E, Grunnet N . Molecular genetics of ABO histo-blood groups. Transfus Clin Biol. 1994; 1(2):79-89. DOI: 10.1016/s1246-7820(94)80001-4. View

Hardie D, JOHNSON G, Khan M, MacLennan I . Quantitative analysis of molecules which distinguish functional compartments within germinal centers. Eur J Immunol. 1993; 23(5):997-1004. DOI: 10.1002/eji.1830230502. View

10.

Lampio A, Airaksinen A, Maaheimo H . UDP-galactose:lactosylceramide alpha-galactosyltransferase activity in human placenta. Glycoconj J. 1993; 10(2):165-9. DOI: 10.1007/BF00737713. View

11.

Ernst L, Rajan V, Larsen R, Ruff M, Lowe J . Stable expression of blood group H determinants and GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferase in mouse cells after transfection with human DNA. J Biol Chem. 1989; 264(6):3436-47. View

12.

Magnani J, Smith D, Ginsburg V . Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. Anal Biochem. 1980; 109(2):399-402. DOI: 10.1016/0003-2697(80)90667-3. View

13.

Berek C, Ziegner M . The maturation of the immune response. Immunol Today. 1993; 14(8):400-4. DOI: 10.1016/0167-5699(93)90143-9. View

14.

Saito T, HAKOMORI S . Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res. 1971; 12(2):257-9. View

15.

Iizuka S, Chen S, Yoshida A . Studies on the human blood group P system: an existence of UDP-Gal:lactosylceramide alpha 1----4 galactosyltransferase in the small p type cells. Biochem Biophys Res Commun. 1986; 137(3):1187-95. DOI: 10.1016/0006-291x(86)90351-7. View

16.

Mollicone R, Candelier J, Reguigne I, Couillin P, Fletcher A, Oriol R . Molecular genetics of alpha-L-fucosyltransferase genes (H, Se, Le, FUT4, FUT5 and FUT6). Transfus Clin Biol. 1994; 1(2):91-7. DOI: 10.1016/s1246-7820(94)80002-2. View

17.

Taga S, Tetaud C, Mangeney M, Tursz T, Wiels J . Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases. Biochim Biophys Acta. 1995; 1254(1):56-65. DOI: 10.1016/0005-2760(94)00167-w. View

18.

Fellous M, Gerbal A, Nobillot G, Weils J . Studies on the biosynthetic pathway of human P erythrocyte antigen using genetic complementation tests between fibroblasts from rare p and Pk phenotype donors. Vox Sang. 1977; 32(5):262-8. DOI: 10.1111/j.1423-0410.1977.tb00641.x. View

19.

Wiels J, Mangeney M, Tetaud C, Tursz T . Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation. Int Immunol. 1991; 3(12):1289-300. DOI: 10.1093/intimm/3.12.1289. View

20.

Thurnher M, Rusconi S, Berger E . Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J Clin Invest. 1993; 91(5):2103-10. PMC: 288210. DOI: 10.1172/JCI116434. View